{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:49:35Z","timestamp":1786135775177,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["K23DK128605"],"award-info":[{"award-number":["K23DK128605"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["JASN"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1681\/asn.0000001055","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:01:06Z","timestamp":1771347666000},"page":"1081-1083","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Acute Kidney Injury as a Safety End Point in Non\u2013Acute Kidney Injury Clinical Trials"],"prefix":"10.1681","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6470-6959","authenticated-orcid":false,"given":"Ian E.","family":"McCoy","sequence":"first","affiliation":[{"name":"Division of Nephrology, University of California San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7599-0534","authenticated-orcid":false,"given":"Glenn M.","family":"Chertow","sequence":"additional","affiliation":[{"name":"Departments of Medicine, Epidemiology and Population Health, and Health Policy, Stanford University School of Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"issue":"11","key":"B1-20260526","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1681\/ASN.2004090740","article-title":"Acute kidney injury, mortality, length of stay, and costs in hospitalized patients","volume":"16","author":"Chertow","year":"2005","journal-title":"J Am Soc Nephrol."},{"issue":"6","key":"B2-20260526","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1097\/01.ASN.0000130340.93930.DD","article-title":"Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study","volume":"15","author":"Lassnigg","year":"2004","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B3-20260526","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2215\/CJN.0000000000000163","article-title":"Probing the association between acute kidney injury and cardiovascular outcomes","volume":"18","author":"McCoy","year":"2023","journal-title":"Clin J Am Soc Nephrol."},{"issue":"8","key":"B4-20260526","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1681\/ASN.2015060642","article-title":"Evaluation of short-term changes in serum creatinine level as a meaningful end point in randomized clinical trials","volume":"27","author":"Coca","year":"2016","journal-title":"J Am Soc Nephrol."},{"issue":"4","key":"B5-20260526","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.ajkd.2019.11.010","article-title":"AKI\u2014A relevant safety end point?","volume":"75","author":"McCoy","year":"2020","journal-title":"Am J Kidney Dis."},{"issue":"11","key":"B6-20260526","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1681\/ASN.2022030306","article-title":"Correlates and consequences of an acute change in eGFR in response to the SGLT2 inhibitor dapagliflozin in patients with CKD","volume":"33","author":"Jongs","year":"2022","journal-title":"J Am Soc Nephrol."},{"issue":"8","key":"B7-20260526","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1681\/ASN.2021121605","article-title":"Optimizing the design and analysis of future AKI trials","volume":"33","author":"Legrand","year":"2022","journal-title":"J Am Soc Nephrol."},{"issue":"7","key":"B8-20260526","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s00134-024-07480-x","article-title":"Heterogeneity in the definition of major adverse kidney events: a scoping review","volume":"50","author":"Maeda","year":"2024","journal-title":"Intensive Care Med."},{"key":"B9-20260526","first-page":"1","article-title":"Pre-renal azotemia: a flawed paradigm in critically ill septic patients?","volume":"156","author":"Bellomo","year":"2007","journal-title":"Contrib Nephrol."},{"issue":"9","key":"B10-20260526","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1681\/ASN.2015070829","article-title":"Candidate surrogate end points for ESRD after AKI","volume":"27","author":"Grams","year":"2016","journal-title":"J Am Soc Nephrol."}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:49:27Z","timestamp":1786132167000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1681\/ASN.0000001055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.0000001055","relation":{},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]}}}